Getting diagnosed with a sexually transmitted infection means acting quickly on a few fronts: confirming the diagnosis with the right test, starting treatment, notifying sexual partners, and scheduling follow-up. Most bacterial STIs are curable with a short course of antibiotics, and viral ones like herpes can be managed with daily medication that dramatically cuts transmission risk. The steps themselves are straightforward, but each one has nuances that determine whether you actually protect your health and the health of others.
Many STIs Show No Symptoms, So Get Tested Properly
If you suspect exposure but feel fine, do not assume you are in the clear. Research estimates that the vast majority of chlamydia cases and nearly half of gonorrhea cases never produce noticeable symptoms.1PubMed. Asymptomatic sexually transmitted diseases: the case for screening That means waiting for something to feel wrong is not a reliable strategy. In one study of HIV-positive men attending routine care with no STI complaints, about one in six turned out to have an undiagnosed sexually transmitted infection.2PubMed. High prevalence of asymptomatic sexually transmitted infections in HIV-infected men who have sex with men: a stimulus to improve screening
The type of test matters, especially for HIV. Standard antibody-based screening tests miss very recent infections because your body has not yet produced enough antibodies to trigger a positive result. Nucleic acid amplification testing can detect HIV roughly a month earlier than older-generation antibody tests and nearly a week sooner than the newest fourth-generation combination tests.3Archives of Internal Medicine. Detecting Acute Human Immunodeficiency Virus Infection Using 3 Different Screening Immunoassays and Nucleic Acid Amplification Testing for Human Immunodeficiency Virus RNA, 2006-2008 If you had a high-risk exposure in the last few weeks, ask your provider specifically about nucleic acid testing rather than relying on a standard rapid test alone.
For chlamydia and gonorrhea, urine-based nucleic acid tests are the standard and are highly accurate. If you are uncomfortable visiting a clinic, home specimen collection kits now exist and perform nearly as well. A systematic review found that self-collected vaginal swabs taken at home matched clinic-collected samples with roughly 97% agreement for chlamydia and 92% for gonorrhea.4BMJ. At-home specimen self-collection as an additional testing strategy for chlamydia and gonorrhoea: a systematic literature review and meta-analysis These kits are not a substitute for a provider visit if you have active symptoms, but they remove one of the biggest barriers to getting checked in the first place.
Start Treatment and Finish It
Once you have a confirmed diagnosis, the treatment path depends on which infection you have. The good news is that the most common bacterial STIs are curable. Chlamydia typically requires just a single dose of antibiotics. Primary syphilis can also be treated with a single injection of benzathine penicillin.5BMJ. Should we abandon “finishing the course” of antimicrobials? Gonorrhea is usually treated with a single intramuscular injection of ceftriaxone. The key point: even though treatment is fast, you need to follow the prescribed regimen exactly and avoid sexual contact until treatment is complete and, ideally, until a follow-up test confirms you have cleared the infection.
Gonorrhea deserves special mention because it is becoming harder to treat. The bacterium that causes it has developed resistance to virtually every antibiotic previously used against it, and strains resistant to ceftriaxone, the current frontline drug, are now spreading globally. Dual resistance to both ceftriaxone and azithromycin has also been documented.6New Microbes and New Infections. Antimicrobial resistance crisis in STIs: Gonorrhea and M. genitalium on the brink of untreatability This does not mean gonorrhea is untreatable today, but it means your provider may need to do a test of cure after treatment to make sure the antibiotics worked. If you are treated for gonorrhea and symptoms persist, go back immediately rather than assuming the infection will resolve on its own.
Managing Herpes and Other Viral STIs
Viral infections like herpes (HSV-2) and HIV are not curable, but they are manageable. If you have been diagnosed with genital herpes, daily antiviral medication is one of the most important steps you can take, both for your own comfort and for your partners’ safety. In a large randomized trial, people with HSV-2 who took daily valacyclovir cut their rate of transmitting herpes to a susceptible partner roughly in half. Among partners of those who took the drug, only about 2% acquired HSV-2, compared to about 4% in the placebo group.7PubMed. Once-daily valacyclovir to reduce the risk of transmission of genital herpes
Daily antivirals also dramatically reduce how often the virus shows up in genital secretions. Viral shedding, which is when the virus is present on the skin or mucous membranes even without a visible sore, dropped from about 11% of days without medication to about 3% of days with daily valacyclovir.7PubMed. Once-daily valacyclovir to reduce the risk of transmission of genital herpes This reduction is significant, though it is not perfect. Research on higher-dose antiviral regimens has shown that even aggressive treatment cannot completely eliminate brief episodes of viral shedding, which are usually subclinical and last only hours.8The Lancet. Effect of standard-dose and high-dose daily antiviral therapy on short-term herpes simplex virus type 2 (HSV-2) shedding This explains why daily suppressive therapy, while strongly recommended, does not reduce transmission risk to zero. Combining antivirals with consistent condom use gives the best protection.
For HIV, antiretroviral therapy (ART) has transformed the infection from a fatal illness to a chronic, manageable condition. When someone with HIV achieves and maintains an undetectable viral load through consistent ART, the risk of sexual transmission drops essentially to zero, a concept often summarized as “undetectable equals untransmittable.” Getting on ART quickly after diagnosis is one of the single most consequential steps a person with HIV can take.
Tell Your Partners
This is the step most people dread, and understandably so. But notifying recent sexual partners is essential for two reasons: it protects them from unknowingly spreading the infection further, and it protects you from getting reinfected by an untreated partner. For curable infections like chlamydia and gonorrhea, reinfection from an untreated partner is one of the most common reasons people test positive again after successful treatment.
You generally have a few options for how to handle notification. You can tell partners directly, which gives you the most control over the conversation. Many clinics also offer anonymous notification, where public health staff contact your partners without revealing your identity. A third route, available in many U.S. states and some other countries, is expedited partner therapy, where your provider gives you a prescription or medication packet that you hand directly to your partner so they can start treatment without needing a separate clinic visit first.
Expedited partner therapy has a solid evidence base. Randomized trials have consistently shown that it increases the chance that partners actually get treated and decreases the rate of reinfection. A pooled analysis found the approach cut persistent or recurrent gonorrhea by about two-thirds and reduced chlamydia reinfection by roughly a fifth, with partners being significantly more likely to have been treated compared to standard referral.9Sexually Transmitted Diseases. Expedited Partner Therapy: A Robust Intervention Separate community-level research has confirmed that expedited partner therapy increases partner treatment and decreases reinfection with both gonorrhea and chlamydia.10PLOS Medicine. Uptake and Population-Level Impact of Expedited Partner Therapy (EPT) on Chlamydia trachomatis and Neisseria gonorrhoeae
Digital tools are also emerging. In England, clinics using a digital partner notification platform roughly doubled the number of partners who came in for testing per patient diagnosed with gonorrhea, and noticeably increased partner testing for syphilis as well.11Sexually Transmitted Diseases. An Evaluation of Digital Partner Notification Tool Engagement and Impact for Patients Diagnosed With Gonorrhea and Syphilis If face-to-face conversations feel impossible, ask your clinic whether they offer anonymous texting or email-based notification services.
How People Navigate Disclosure
Research on how people actually handle telling partners reveals a wide range of approaches. Some people use direct disclosure, telling a partner outright before sexual activity. Others use priming messages, gradually introducing the topic or framing it in a particular way to control the reaction. And some people avoid disclosure entirely, using strategies like timing sexual activity around symptom-free periods or withdrawing from relationships altogether to sidestep the conversation.12Taylor & Francis Online (PubMed Central). Disclosure of Sexually Transmitted Infections to Sexual Partners: A Systematic Critical Literature Review
Among studies that looked at the timing of disclosure, roughly half or fewer people disclosed their infection before having sex with a partner.12Taylor & Francis Online (PubMed Central). Disclosure of Sexually Transmitted Infections to Sexual Partners: A Systematic Critical Literature Review The biggest predictor of whether someone disclosed was the nature of the relationship: people in more committed, longer-term, or emotionally close relationships were substantially more likely to tell their partner. This tracks with common sense. It is easier to have a vulnerable conversation with someone you trust than with a casual partner you barely know. But casual partners still deserve to make informed decisions about their own health, which is where anonymous notification and clinic-based tools can bridge the gap.
Schedule a Retest
Treatment is not the end of the process. For chlamydia and gonorrhea in particular, retesting roughly three months after treatment is strongly recommended, regardless of whether your symptoms resolved. The reason is that reinfection rates are surprisingly high. A systematic review of studies in men found a median chlamydia reinfection rate of about 11% and a gonorrhea reinfection rate of about 7%.13BMJ Journals. Chlamydial and gonococcal reinfection among men: a systematic review of data to evaluate the need for retesting These are people who were successfully treated the first time. The high reinfection rate usually means an untreated partner passed the infection back, or a new partner was carrying it.
For syphilis, follow-up blood tests are needed at specific intervals (typically at 6 and 12 months after treatment) to confirm that antibody levels are declining as expected, which signals the treatment worked. HIV requires ongoing viral load monitoring as part of lifelong antiretroviral therapy. Your provider will set a schedule, but the key takeaway is the same across all STIs: a single negative test after treatment does not mean you are done. Build the follow-up visits into your calendar.
What Happens When STIs Go Untreated
The urgency behind all of these steps comes from the potential consequences of leaving an infection untreated. For chlamydia and gonorrhea, the most serious risk for women is pelvic inflammatory disease, an infection of the upper reproductive tract that can cause chronic pain, scarring, and lasting damage to the fallopian tubes. Multiple studies have linked untreated chlamydia and gonorrhea to tubal factor infertility and ectopic pregnancy.14PubMed Central. Sexually transmitted diseases and infertility Retrospective studies using blood tests for past chlamydial infection have repeatedly identified it as a major contributor to tubal infertility.15Infectious Disease Clinics of North America. Pelvic Inflammatory Disease and Infertility in Women
Untreated syphilis progresses through stages over years, eventually affecting the heart, brain, and nervous system. Untreated HIV leads to progressive immune destruction and, ultimately, AIDS. Even gonorrhea, which many people think of as a minor inconvenience, can spread to the bloodstream and joints if left alone. The basic message is that STIs are not infections you can safely ignore or wait out.
STIs During Pregnancy
Pregnancy adds urgency to every part of this process. Syphilis can cross the placenta and infect the fetus, causing stillbirth, severe birth defects, and neonatal death. International guidelines call for universal syphilis screening at the first prenatal visit, with repeat screening at delivery in countries that have not yet met elimination targets.16PubMed Central. Syphilis in pregnancy: A practical guide for prenatal care providers Benzathine penicillin remains the recommended treatment and is both effective and safe during pregnancy. Partner treatment is also recommended to prevent maternal reinfection.16PubMed Central. Syphilis in pregnancy: A practical guide for prenatal care providers
Chlamydia and gonorrhea during pregnancy can cause premature rupture of membranes, preterm birth, and neonatal eye infections. HIV can be transmitted during delivery or breastfeeding but is preventable with antiretroviral therapy. Herpes poses a risk primarily during an active outbreak at the time of delivery, which is why providers may recommend antiviral suppression in the final weeks of pregnancy or a cesarean section if active lesions are present. If you are pregnant and have any STI, your obstetrician needs to know immediately so they can tailor the treatment and delivery plan.
Dealing With the Emotional Fallout
An STI diagnosis carries a psychological burden that often gets overlooked in the clinical rush to prescribe antibiotics. Shame, anxiety, and fear of social rejection are extremely common responses. Research on people diagnosed with syphilis found that infected individuals experienced significantly more acute stress than healthy controls, and that women in particular tended to cope by avoidance and withdrawal rather than actively seeking support.17Ginekologia Polska. Management of the stressful stigma attached to sexually transmitted disease (preliminary report) The awareness of potential social consequences was a powerful motivator to keep the diagnosis secret, which in turn can deepen isolation and delay partner notification.
If you are feeling overwhelmed after a diagnosis, recognize that this reaction is normal and well-documented. Talking to a counselor, especially one experienced with sexual health, can help you process the diagnosis and develop a plan for disclosure without spiraling into shame. Many STI clinics offer counseling as part of the visit. Online peer support communities can also reduce the feeling that you are dealing with this alone. The emotional side of an STI is real, but it should not be a reason to delay the practical steps that protect your health and your partners’.
Overcoming Cost and Access Barriers
Knowing what to do is only useful if you can actually access care. Cost is consistently identified as one of the biggest obstacles to STI testing and treatment, especially for younger people. In focus groups, adolescents and young adults repeatedly stressed that out-of-pocket expenses were a major deterrent and that free or low-cost services would make them far more likely to seek care.18PubMed Central. Barriers to asymptomatic screening and other STD services for adolescents and young adults: focus group discussions Beyond cost, people also cited fear of invasive procedures, embarrassment during genital exams, and worry about being judged by their provider.19PubMed Central. Barriers to sexually transmitted infection testing in New Zealand: a qualitative study
In the United States, publicly funded STI clinics, Title X family planning clinics, and community health centers offer testing and treatment on a sliding fee scale, and many provide services at no cost. Planned Parenthood locations offer STI services regardless of insurance status. County and city health departments often run free testing events, particularly for HIV and syphilis. If cost is a barrier, call your local health department to ask what is available before assuming you cannot afford to be seen. For those who are insured, most plans are required to cover STI screening without cost-sharing for certain at-risk groups under the Affordable Care Act.
Legal Dimensions of STI Disclosure
Many people wonder whether they are legally required to tell sexual partners about an STI. The answer depends heavily on where you live and which infection is involved. Most jurisdictions have specific laws around HIV disclosure, and some extend criminal penalties to other infections like syphilis, gonorrhea, and herpes in certain circumstances. In the United States, these laws vary dramatically by state. Research comparing two states with similar HIV rates found that the state with harsher penalties for nondisclosure had stricter counseling procedures and providers who were more supportive of criminalization, while providers in the state with less punitive laws were more likely to view strict mandates as a barrier to patient care.20PubMed. “Notify your partners–it’s the law”: HIV providers and mandatory disclosure
The legal landscape is contentious. Public health advocates increasingly argue that criminalizing nondisclosure can discourage people from getting tested in the first place, since you cannot be penalized for not disclosing a diagnosis you never received. Regardless of your view on these laws, the practical advice is simple: ask your provider or local health department what your state or country requires. For HIV specifically, many jurisdictions consider an undetectable viral load when evaluating disclosure obligations, though the legal standard varies. Being informed about the law where you live is part of managing your diagnosis responsibly.
Protecting Yourself Going Forward
An STI diagnosis is not the end of your sexual life. Once treated or managed, the focus shifts to reducing the risk of future infections. Consistent and correct condom use remains one of the most effective tools, offering strong protection against HIV, hepatitis B, and gonorrhea.21PubMed Central. Condoms: Past, present, and future Condoms are somewhat less effective against infections spread through skin-to-skin contact beyond the area a condom covers, like herpes and HPV, but they still reduce risk meaningfully.
For HIV prevention specifically, pre-exposure prophylaxis (PrEP) is available for people at ongoing risk. PrEP involves taking a daily pill or receiving a long-acting injection that reduces the chance of acquiring HIV by well over 90% when used consistently. If your partner is HIV-positive or if you have multiple sexual partners and inconsistent condom use, talk to a provider about PrEP.
Vaccination is another layer of protection. The HPV vaccine prevents the strains of human papillomavirus most commonly linked to cervical cancer, anal cancer, and genital warts. Hepatitis A and B vaccines are recommended for anyone at increased risk, including men who have sex with men and people with multiple partners. These vaccines are safe, widely available, and prevent infections that are otherwise difficult or impossible to cure. Combining vaccination, barrier methods, regular screening, and prompt treatment for any new infections creates a practical, multi-layered defense that lets you stay sexually active while minimizing risk to yourself and others.